THE COLUMN GROUP
The Column Group is a leading venture capital firm dedicated to creating the next generation of biotechnology companies
THE COLUMN GROUP
Social Links:
Industry:
Biotechnology Finance Financial Services Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
(415) 255-2048
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CPanel SSL GoDaddy EasyDNS
Similar Organizations
Greenoaks Capital
Greenoaks is a global investment firm specializing in technology companies.
Motley Fool Ventures
Motley Fool Ventures is a venture capital that primarily invests in tech-enabled companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-26 | Carmot Therapeutics | The Column Group investment in Series D - Carmot Therapeutics | 160 M USD |
| 2022-05-17 | Remix Therapeutics | The Column Group investment in Series B - Remix Therapeutics | 70 M USD |
| 2022-02-23 | Plexium | The Column Group investment in Series B - Plexium | 102 M USD |
| 2022-02-15 | Kallyope | The Column Group investment in Series D - Kallyope | 236 M USD |
| 2022-01-06 | Eikon Therapeutics | The Column Group investment in Series B - Eikon Therapeutics | 518 M USD |
| 2021-09-22 | Hexagon Bio | The Column Group investment in Series B - Hexagon Bio | 61 M USD |
| 2021-09-09 | Obsidian Therapeutics | The Column Group investment in Series B - Obsidian Therapeutics | 115 M USD |
| 2021-08-26 | Effector Therapeutics | The Column Group investment in Post-IPO Equity - Effector Therapeutics | 60 M USD |
| 2021-08-24 | Atavistik Bio | The Column Group investment in Series A - Atavistik Bio | 60 M USD |
| 2021-08-12 | Surrozen | The Column Group investment in Post-IPO Equity - Surrozen | 120 M USD |